BR100 Decreased By (-0.21%)
BR30 Decreased By (-0.19%)
KSE100 Decreased By (-0.03%)
KSE30 Decreased By (-0.11%)
AGHA 7.72 Decreased By ▼ -0.09 (-1.15%)
BECO 5.18 Decreased By ▼ -0.03 (-0.58%)
BML 57.50 No Change ▼ 0.00 (0%)
BOP 33.89 Decreased By ▼ -0.14 (-0.41%)
CNERGY 9.97 Increased By ▲ 0.01 (0.1%)
CSIL 5.35 Increased By ▲ 0.04 (0.75%)
FCCL 54.42 Decreased By ▼ -0.28 (-0.51%)
FFL 16.69 No Change ▼ 0.00 (0%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 7.33 Decreased By ▼ -0.07 (-0.95%)
KOSM 5.71 Decreased By ▼ -0.06 (-1.04%)
LOTCHEM 29.16 Decreased By ▼ -0.16 (-0.55%)
MLCF 93.49 Decreased By ▼ -0.87 (-0.92%)
NBP 202.60 Decreased By ▼ -0.45 (-0.22%)
NCPL 56.70 Decreased By ▼ -0.30 (-0.53%)
NPL 67.55 Decreased By ▼ -0.15 (-0.22%)
OGDC 316.39 Increased By ▲ 0.55 (0.17%)
PACE 10.64 No Change ▼ 0.00 (0%)
PAEL 43.10 Decreased By ▼ -0.10 (-0.23%)
PIBTL 16.65 Decreased By ▼ -0.09 (-0.54%)
PPL 218.87 Decreased By ▼ -0.91 (-0.41%)
PRL 49.85 Increased By ▲ 0.66 (1.34%)
PTC 71.00 Increased By ▲ 0.47 (0.67%)
SSGC 27.98 Decreased By ▼ -0.27 (-0.96%)
TBL 9.83 Decreased By ▼ -0.03 (-0.3%)
TELE 8.75 Decreased By ▼ -0.04 (-0.46%)
TPL 17.99 Decreased By ▼ -0.25 (-1.37%)
TPLP 13.48 Increased By ▲ 0.21 (1.58%)
TREET 22.75 Increased By ▲ 0.03 (0.13%)
TRG 60.01 Decreased By ▼ -0.13 (-0.22%)
Pakistan

Pakistan to receive 17.2 million COVID-19 doses through COVAX

  • The distribution list includes doses of the AstraZeneca-Oxford vaccine, licensed to the Serum Institute of India, Pfizer-BioNTech vaccine and AstraZeneca-Oxford vaccine.
  • The distribution aims to cover an average of 3.3% of total population of 145 countries by mid-2021.
Published Updated

Pakistan will get 17.2 million doses of coronavirus vaccines through the COVAX facility.

COVAX is co-led by the GAVI alliance which secures vaccines for poor countries, the World Health Organization, the Coalition for Epidemic Preparedness Innovations and the UN Children’s Fund.

The COVAX programme published its first distribution list in which it aims to deliver vaccines in the first half of 2021. COVAX has allocated at least 330 million doses of coronavirus vaccines for poorer countries. The distribution would cover an average of 3.3% of total population of 145 countries by mid-2021.

"This is in line with the Facility target to reach at least 3% population coverage in all countries in the first half of the year, enough to protect the most vulnerable groups such as health care workers," a statement by the programme said.

The distribution list includes 240m doses of the AstraZeneca-Oxford vaccine, licensed to the Serum Institute of India (SII); 1.2m doses of the Pfizer-BioNTech vaccine and 96m doses of AstraZeneca-Oxford vaccine.

According to the document, countries will receive doses in proportion to their population size. Pakistan will be getting 17.2 million doses, India 97.2m, Nigeria 16 million, Indonesia 13.7 million, Bangladesh 12.8 million and Brazil 10.6 million.

Comments

Comments are closed for this article.